What is the market capitalization of MEDICURE INC?

MEDICURE INC (MPH.V) has a market capitalization of approximately 11,584,307 CAD.

Where can I buy MPH.V in Canada?

MPH.V can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

MPH.V

MEDICURE INC

MEDICURE INC (MPH.V) is a Canadian company in the healthcare sector, listed on TSXV. Market capitalization of 12 million CAD (micro-cap).

Details

Price1.11 CAD

Market cap11.58 M CAD

Payout ratio0.00%

ROE-41.57%

Debt / Equity6.34%

SectorHealthcare

Websitemedicure.com

Updated 3h ago

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order, and online pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.